CINDY MOLINA: Open Payments
NPI 1487209250 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 25 payments from 9 companies in 2025. Trend: 2023 $1,188 · 2024 $1,488 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $258 |
| Optinose US, Inc. | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| Smith+Nephew, Inc. | 2 | $87 |
| GlaxoSmithKline, LLC. | 1 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Lilly USA, LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: RINVOQ, Xhance, VOQUEZNA, NUCALA, TULA, DUPIXENT, AIRSUPRA, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
